PODNOS YALE (Chief Medical Officer) sold 8.3% of their position (23.45K shares) of STARLING ONCOLOGY, INC. on the open market
Open‑market sale worth $150.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+17.97K
Price / share
$1.87
Trade value
$33.61K
% of position
Common Stock
Shares
−17.97K
Price / share
$6.43
Trade value
$115.55K
% of position
Common Stock
Shares
+5.48K
Price / share
$2.00
Trade value
$10.96K
% of position
Common Stock
Shares
−5.48K
Price / share
$6.35
Trade value
$34.79K
% of position
Net shares
+0.00
Net value
-$105.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/14/2026 | M · Option Exercise | +17.97K | $1.87 | $33.61K | 6.9% | 259.53K | 277.50K |
| Common Stock Direct | 7/14/2026 | S · Sale | −17.97K | $6.43 | $115.55K | 6.5% | 277.50K | 259.53K |
| Common Stock Direct | 7/14/2026 | M · Option Exercise | +5.48K | $2.00 | $10.96K | 2.1% | 259.53K | 265K |
| Common Stock Direct | 7/14/2026 | S · Sale | −5.48K | $6.35 | $34.79K | 2.1% | 265K | 259.53K |
| Total | +0.00 | -$105.77K | ||||||
Stock Option (Right to Buy)
Common Stock
17.97K shares
Shares
+17.97K
Strike price
1.87
Held after
0.00
Exercisable
—
Stock Option (Right to Buy)
Common Stock
5.48K shares
Shares
+5.48K
Strike price
2.00
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock17.97K shares | 7/14/2026 | M · Option Exercise | +17.97K | 1.87 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock5.48K shares | 7/14/2026 | M · Option Exercise | +5.48K | 2.00 | — | 0.00 |